Mondrian Investment Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,191
| Closed | -$922K | – | 99 |
|
|
2024
Q4 | $922K | Sell |
5,191
-639,094
| -99% | -$114M | 0.02% | 70 |
|
|
2024
Q3 | $127M | Sell |
644,285
-199,612
| -24% | -$39.4M | 1.93% | 22 |
|
|
2024
Q2 | $156M | Sell |
843,897
-72,006
| -8% | -$13.3M | 2.41% | 10 |
|
|
2024
Q1 | $167M | Sell |
915,903
-51,920
| -5% | -$9.45M | 2.29% | 15 |
|
|
2023
Q4 | $150M | Buy |
967,823
+12,287
| +1% | +$1.9M | 2.37% | 10 |
|
|
2023
Q3 | $142M | Sell |
955,536
-132,802
| -12% | -$19.8M | 2.93% | 5 |
|
|
2023
Q2 | $147M | Buy |
1,088,338
+157,027
| +17% | +$21.2M | 2.93% | 10 |
|
|
2023
Q1 | $148M | Buy |
931,311
+70,741
| +8% | +$11.3M | 3.28% | 7 |
|
|
2022
Q4 | $139M | Sell |
860,570
-190,962
| -18% | -$30.9M | 3.08% | 10 |
|
|
2022
Q3 | $141K | Buy |
1,051,532
+18,126
| +2% | +$2.43K | 3.09% | 10 |
|
|
2022
Q2 | $158M | Buy |
1,033,406
+102,154
| +11% | +$15.6M | 3.31% | 6 |
|
|
2022
Q1 | $151M | Sell |
931,252
-159,274
| -15% | -$25.8M | 3.1% | 11 |
|
|
2021
Q4 | $148M | Buy |
1,090,526
+560,488
| +106% | +$75.9M | 2.92% | 11 |
|
|
2021
Q3 | $57.2M | Buy |
530,038
+73,841
| +16% | +$7.97M | 1.15% | 33 |
|
|
2021
Q2 | $51.4M | Buy |
456,197
+80,593
| +21% | +$9.08M | 0.98% | 34 |
|
|
2021
Q1 | $41.9M | Buy |
375,604
+61,129
| +19% | +$6.82M | 0.9% | 41 |
|
|
2020
Q4 | $33.7M | Buy |
314,475
+104,023
| +49% | +$11.1M | 0.83% | 43 |
|
|
2020
Q3 | $17.9M | Sell |
210,452
-89,564
| -30% | -$7.62M | 0.62% | 43 |
|
|
2020
Q2 | $29.5M | Buy |
+300,016
| New | +$29.5M | 1.06% | 38 |
|